1Pan XR, Yang WY, Li GW, et al. (1997) Prevalence of diabetes and its risk factors in China, 1994. National Diabetes Prevention and Control Cooperative Group. Diabetes Care 20, 1664–1669.
2Gu D, Reynolds K, Duan X, et al. (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 46, 1190–1198.
3Yang WY, Lu JM, Weng JP, et al. (2010) Prevalence of diabetes among men and women in China. New Engl J Med 362, 1090–1101.
4Alberti KG & Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15, 539–553.
5Nathan DM, Davidson MB, DeFronzo RA, et al. (2007) Impaired fasting glucose and impaired glucose tolerance – implications for care. Diabetes Care 30, 753–759.
6Kim NH, Pavkov ME, Looker HC, et al. (2008) Plasma glucose regulation and mortality in pima Indians. Diabetes Care 31, 488–492.
7Levitzky YS, Pencina MJ, D'Agostino RB, et al. (2008) Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 51, 264–270.
8Chien KL, Hsu HC, Su TC, et al. (2008) Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study. Am Heart J 156, 996–1002.
9Bonora E, Kiechl S, Willeit J, et al. (2003) Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 26, 1251–1257.
10Knowler WC, Barrett-Connor E, Fowler SE, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346, 393–403.
11Kosaka K, Noda M & Kuzuya T (2005) Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 67, 152–162.
12Tuomilehto J, Lindstrom J, Eriksson JG, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New Engl J Med 344, 1343–1350.
13Eriksson KF & Lindgarde F (1991) Prevention of Type-2 (non-insulin-dependent) diabetes-mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 34, 891–898.
14Sun JQ, Wang YF, Chen XF, et al. (2008) An integrated intervention program to control diabetes in overweight Chinese women and men with type 2 diabetes. Asia Pac J Clin Nutr 17, 514–524.
15Redmon JB, Raatz SK, Reck KP, et al. (2003) One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes – a radomized trial. Diabetes Care 26, 2505–2511.
16Wadden TA, West DS, Neiberg RH, et al. (2009) One-year weight losses in the Look AHEAD study: factors associated with success. Obesity 17, 713–722.
17Genuth S, Alberti KG, Bennett P, et al. (2003) Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26, 3160–3167.
18Chinese Diabetes Society (2008) 2007 Chinese guidelines for the management of type 2 diabetes. Natl Med J China 88, 1227–1245.
19Chinese Nutrition Society (2008) Dietary Guidelines for Chinese. Beijing: Tibetan People's Publishing House.
20Unick JL, Beavers D, Jakicic JM, et al. (2011) Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care 34, 2152–2157.
21Heymsfield SB, van Mierlo CAJ, van der Knaap HC, et al. (2003) Weight management using a meal replacement strategy: meta and pooling analysis from six studies. Int J Obes Relat Metab Disord 27, 537–549.
22Svetkey LP, Stevens VJ, Brantley PJ, et al. (2008) Comparison of strategies for sustaining weight loss – the weight loss maintenance randomized controlled trial. JAMA 299, 1139–1148.
23Feldstein AC, Nichols GA, Smith DH, et al. (2008) Weight change in diabetes and glycemic and blood pressure control. Diabetes Care 31, 1960–1965.
24Redmon JB, Raatz SK, Reck KP, et al. (2003) One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes: a randomized trial. Diabetes Care 26, 2505–2511.
25Edelstein SL, Knowler WC, Bain RP, et al. (1997) Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studies. Diabetes 46, 701–710.
26Hamman RF, Wing RR, Edelstein SL, et al. (2006) Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 29, 2102–2107.
27Jia WP, Pang C, Chen L, et al. (2007) Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50, 286–292.
28Pan XR, Li GW, Hu YH, et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance – the Da Qing IGT and diabetes study. Diabetes Care 20, 537–544.
29Chiasson JL, Josse RG, Gomis R, et al. (2002) Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 359, 2072–2077.
30Gerstein HC, Yusuf S, Bosch J, et al. (2006) Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368, 1096–1105.
31Perreault L, Kahn SE, Christophi CA, et al. (2009) Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32, 1583–1588.